Product
Hexavalent Vaccine
1 clinical trial
6 indications
Indication
Diphtheria ImmunizationIndication
Tetanus ImmunizationIndication
PertussisIndication
Hepatitis B VaccinationIndication
Polio ImmunizationClinical trial
An Observer-blind, Randomized, Active-controlled, Multi-centric Phase III Study to Assess Immunogenicity and Safety of Hexavalent (DTwP-Hepatitis B-IPV-Hib) Vaccine Containing Reduced Dose IPV in Comparison With HEXASIIL®Status: Recruiting, Estimated PCD: 2025-08-31